# Light, Metabolic Syndrome and Alzheimer's Disease - Aim 2

> **NCT03933696** · NA · COMPLETED · sponsor: **Icahn School of Medicine at Mount Sinai** · enrollment: 25 (actual)

## Conditions studied

- Mild Cognitive Impairment
- Alzheimer Disease
- Type2 Diabetes

## Interventions

- **DEVICE:** Tailored Lighting Intervention

## Key facts

- **NCT ID:** NCT03933696
- **Lead sponsor:** Icahn School of Medicine at Mount Sinai
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-01-02
- **Primary completion:** 2025-05-31
- **Final completion:** 2025-05-31
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2025-09-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03933696

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03933696, "Light, Metabolic Syndrome and Alzheimer's Disease - Aim 2". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT03933696. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*